Disc Medicine
IRON
62 hedge funds and large institutions have $103M invested in Disc Medicine in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 3 closing their positions.
863% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $187K
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
13% more funds holding
Funds holding: 55 → 62 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 1.98% → 1.98% (-0%)
31% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 26
37% less capital invested
Capital invested by funds: $165M → $103M (-$61.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$4.13M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$2.25M |
| 3 |
Millennium Management
New York
|
+$1.54M |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$1.29M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$752K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.61M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.53M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.16M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$926K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$589K |
IRON Hedge Fund Activity: Q3 2021 in Review
62 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q3 2021, worth a combined $103M — down 37% from $165M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new IRON positions and 3 closed out — a net gain of 7 holders — while 18 added to existing stakes and 26 trimmed.
The largest buyer was Franklin Resources, adding an estimated $4.13M. The largest seller was Fidelity Investments, cutting an estimated $4.61M.
- 62 institutional investors held Disc Medicine (IRON) as of Q3 2021, up from 55 in Q2 2021.
- Funds reported $103M of Disc Medicine stock for Q3 2021, down 37% quarter-over-quarter.
- 10 funds opened new Disc Medicine positions in Q3 2021 and 3 closed out, a net change of +7 holders.
- The largest Disc Medicine buyer in Q3 2021 was Franklin Resources, an estimated $4.13M added.
- The largest Disc Medicine seller in Q3 2021 was Fidelity Investments, an estimated $4.61M sold.
Based on aggregated 13F filings for Q3 2021.